- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06412367
FUNCTIONAL ASSESSMENT FOR SURGERY BY A TIMED WALK (FAST Walk)
May 8, 2024 updated by: Duminda Wijeysundera, Unity Health Toronto
The FAST Walk study aims to determine whether a walking test called the 6-minute walk test (6MWT) can help identify people who are more likely to experience complications after surgery.
This test will be completed before surgery.
We hope that the results of this study will help improve care for patients having major surgery in the future.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1672
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Duminda N Wijeysundera, MD PhD FRCPC
- Phone Number: 416-864-5825
- Email: d.wijeysundera@utoronto.ca
Study Contact Backup
- Name: Janneth Pazmino-Canizares, MSc
- Phone Number: 49561 4168646060
- Email: Janneth.Pazmino-Canizares@unityhealth.to
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The sample will include adults who warrant preoperative risk assessment for inpatient non-cardiac surgery.
To identify patients at elevated risk for complications, participants must be aged ≥40 y and have ≥1 risk factor for postoperative complications.
Description
Inclusion Criteria:
- Age ≥40 years
- ≥1 risk factors for postoperative complications
- Elective non-cardiac surgery with expected post-surgery stay ≥2 days
- Preoperative 6MWT is feasible
- Working knowledge of official language(s) in country of study recruitment
Exclusion Criteria:
- Endovascular surgery
- Lower limb orthopedic surgery
- Contraindications to 6MWT
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative complications
Time Frame: 30 days after surgery
|
Major postoperative complications grade II to V in Clavien-Dindo scheme
|
30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Days alive and out of the hospital
Time Frame: 30 days after surgery
|
Postoperative functional recovery measured counting number of days patient is alive and not in hospital
|
30 days after surgery
|
Significant new disability
Time Frame: 90 days after surgery
|
Postoperative functional recovery measured by new disability after surgery
|
90 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Duminda N Wijeysundera, MD PhD FRCPC, Unity Health Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
September 1, 2029
Study Registration Dates
First Submitted
May 8, 2024
First Submitted That Met QC Criteria
May 8, 2024
First Posted (Actual)
May 14, 2024
Study Record Updates
Last Update Posted (Actual)
May 14, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-065
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Complications
-
Marmara UniversityHacettepe University; Cukurova University; Gazi University; Baskent University; Istanbul... and other collaboratorsNot yet recruitingComplications, PostoperativeTurkey
-
Syed HusainRecruitingComplications, PostoperativeUnited States
-
Vastra Gotaland RegionRecruitingSurgery | Lung Infection | Complications, PostoperativeSweden
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
University of PittsburghCompletedLiver Transplant; Complications | Perioperative/Postoperative ComplicationsUnited States
-
Wake Forest University Health SciencesTerminatedPerioperative/Postoperative ComplicationsUnited States
-
Technical University of MunichHealth Information Management, BelgiumActive, not recruitingPerioperative/Postoperative Complications
-
Atatürk Chest Diseases and Chest Surgery Training...CompletedPerioperative/Postoperative ComplicationsTurkey
-
Namigar TurgutCompletedPerioperative/Postoperative ComplicationsTurkey
-
TC Erciyes UniversityCompletedPerioperative/Postoperative ComplicationsTurkey